| | |
Page
|
| |||
招股説明書副刊
|
| ||||||
關於本招股説明書副刊
|
| | | | S-1 | | |
前瞻性陳述
|
| | | | S-2 | | |
Summary
|
| | | | S-4 | | |
The Offering
|
| | | | S-7 | | |
Risk Factors
|
| | | | S-8 | | |
Use of Proceeds
|
| | | | S-14 | | |
Dividend Policy
|
| | | | S-14 | | |
Dilution | | | | | S-15 | | |
Plan of Distribution
|
| | | | S-16 | | |
Legal Matters
|
| | | | S-18 | | |
Experts | | | | | S-18 | | |
您可以在哪裏找到更多信息
|
| | | | S-18 | | |
參考合併的信息
|
| | | | S-19 | | |
|
ABOUT THIS PROSPECTUS
|
| | | | 1 | | |
|
AGILE THERAPEUTICS, INC
|
| | | | 2 | | |
|
前瞻性陳述
|
| | | | 3 | | |
|
RISK FACTORS
|
| | | | 3 | | |
|
USE OF PROCEEDS
|
| | | | 3 | | |
|
股本説明
|
| | | | 4 | | |
|
認股權證説明
|
| | | | 7 | | |
|
債務證券説明
|
| | | | 9 | | |
|
DESCRIPTION OF RIGHTS
|
| | | | 16 | | |
|
DESCRIPTION OF UNITS
|
| | | | 17 | | |
|
PLAN OF DISTRIBUTION
|
| | | | 18 | | |
|
LEGAL MATTERS
|
| | | | 20 | | |
|
EXPERTS
|
| | | | 20 | | |
|
您可以在哪裏找到更多信息
|
| | | | 20 | | |
|
通過引用合併的信息
|
| | | | 20 | | |
|
假設每股公開發行價
|
| | | $ | 0.11 | | |
|
2021年12月31日每股有形賬面淨值
|
| | | $ | 0.08 | | |
|
可歸因於新投資者購買此次發行股票的每股有形賬面淨值增加
|
| | | $ | 0.01 | | |
|
本次發行後調整後的每股有形賬面淨值
|
| | | $ | 0.09 | | |
|
在此次發行中向新投資者每股攤薄
|
| | | $ | 0.02 | | |
|
ABOUT THIS PROSPECTUS
|
| | | | 1 | | |
|
AGILE THERAPEUTICS, INC
|
| | | | 2 | | |
|
前瞻性陳述
|
| | | | 3 | | |
|
RISK FACTORS
|
| | | | 3 | | |
|
USE OF PROCEEDS
|
| | | | 3 | | |
|
股本説明
|
| | | | 4 | | |
|
認股權證説明
|
| | | | 7 | | |
|
債務證券説明
|
| | | | 9 | | |
|
DESCRIPTION OF RIGHTS
|
| | | | 16 | | |
|
DESCRIPTION OF UNITS
|
| | | | 17 | | |
|
PLAN OF DISTRIBUTION
|
| | | | 18 | | |
|
LEGAL MATTERS
|
| | | | 20 | | |
|
EXPERTS
|
| | | | 20 | | |
|
您可以在哪裏找到更多信息
|
| | | | 20 | | |
|
通過引用合併的信息
|
| | | | 20 | | |